{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:10:26Z","timestamp":1790885426452,"version":"4.1.0"},"reference-count":86,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004374","name":"Chongqing Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genes & Diseases"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.gendis.2025.101967","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T07:57:29Z","timestamp":1765180649000},"page":"101967","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ferroptosis and prostate cancer: A translational path from molecular mechanisms to precision therapy"],"prefix":"10.1016","volume":"13","author":[{"given":"Yixiang","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanxin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiachen","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2607-3665","authenticated-orcid":false,"given":"Tanjing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.gendis.2025.101967_bib1","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.3390\/molecules27175730","article-title":"Prostate cancer review: genetics, diagnosis, treatment options, and alternative approaches","volume":"27","author":"Sekhoacha","year":"2022","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.gendis.2025.101967_bib2","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"22","key":"10.1016\/j.gendis.2025.101967_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214257","article-title":"Complexities of prostate cancer","volume":"23","author":"Wasim","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.gendis.2025.101967_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41391-022-00583-w","article-title":"The role of ferroptosis in prostate cancer: a novel therapeutic strategy","volume":"26","author":"Wang","year":"2023","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"10.1016\/j.gendis.2025.101967_bib5","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12894-024-01472-1","article-title":"Identification of ferroptosis related genes and pathways in prostate cancer cells under erastin exposure","volume":"24","author":"Wu","year":"2024","journal-title":"BMC Urol"},{"key":"10.1016\/j.gendis.2025.101967_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103732","article-title":"Molecular mechanisms of ferroptosis and its role in prostate cancer therapy","volume":"176","author":"Wang","year":"2022","journal-title":"Crit Rev Oncol Hematol"},{"issue":"7","key":"10.1016\/j.gendis.2025.101967_bib7","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1039\/D3BM01894F","article-title":"Ferroptosis and ferroptosis-inducing nanomedicine as a promising weapon in combination therapy of prostate cancer","volume":"12","author":"Huang","year":"2024","journal-title":"Biomater Sci"},{"issue":"6","key":"10.1016\/j.gendis.2025.101967_bib8","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1021\/acs.est.4c12341","article-title":"Peroxide directing the iron cycling for tailored generation of active oxidants in aqueous Fenton reactions","volume":"59","author":"Li","year":"2025","journal-title":"Environ Sci Technol"},{"issue":"2","key":"10.1016\/j.gendis.2025.101967_bib9","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1039\/D3NA00877K","article-title":"Liposome-coated nanoparticle triggers prostate cancer ferroptosis through synergetic chemodynamic-gas therapy","volume":"6","author":"Hong","year":"2024","journal-title":"Nanoscale Adv"},{"key":"10.1016\/j.gendis.2025.101967_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103597","article-title":"Hippo pathway activation mediates cardiomyocyte ferroptosis to promote dilated cardiomyopathy through downregulating NFS1","volume":"82","author":"She","year":"2025","journal-title":"Redox Biol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101967_bib11","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13045-023-01442-4","article-title":"Myeloid-like tumor hybrid cells in bone marrow promote progression of prostate cancer bone metastasis","volume":"16","author":"Ye","year":"2023","journal-title":"J Hematol Oncol"},{"issue":"7784","key":"10.1016\/j.gendis.2025.101967_bib12","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","article-title":"The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis","volume":"575","author":"Bersuker","year":"2019","journal-title":"Nature"},{"issue":"7784","key":"10.1016\/j.gendis.2025.101967_bib13","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","article-title":"FSP1 is a glutathione-independent ferroptosis suppressor","volume":"575","author":"Doll","year":"2019","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.gendis.2025.101967_bib14","doi-asserted-by":"crossref","DOI":"10.1172\/JCI166647","article-title":"RB1-deficient prostate tumor growth and metastasis are vulnerable to ferroptosis induction via the E2F\/ACSL4 axis","volume":"133","author":"Wang","year":"2023","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.gendis.2025.101967_bib15","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/pros.24308","article-title":"ATF6\u03b1 promotes prostate cancer progression by enhancing PLA2G4A-mediated arachidonic acid metabolism and protecting tumor cells against ferroptosis","volume":"82","author":"Zhao","year":"2022","journal-title":"Prostate"},{"key":"10.1016\/j.gendis.2025.101967_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117472","article-title":"FTH1P8 induces and transmits docetaxel resistance by inhibiting ferroptosis in prostate cancer","volume":"180","author":"Lu","year":"2024","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"10.1016\/j.gendis.2025.101967_bib17","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41585-024-00869-9","article-title":"Unlocking ferroptosis in prostate cancer: the road to novel therapies and imaging markers","volume":"21","author":"Cao","year":"2024","journal-title":"Nat Rev Urol"},{"issue":"23","key":"10.1016\/j.gendis.2025.101967_bib18","doi-asserted-by":"crossref","first-page":"5948","DOI":"10.1158\/0008-5472.CAN-20-3607","article-title":"Supraphysiologic testosterone induces ferroptosis and activates immune pathways through nucleophagy in prostate cancer","volume":"81","author":"Kumar","year":"2021","journal-title":"Cancer Res"},{"key":"10.1016\/j.gendis.2025.101967_bib19","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.54166","article-title":"Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis","volume":"9","author":"Nassar","year":"2020","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.gendis.2025.101967_bib20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41419-024-06464-5","article-title":"CYLD regulates cell ferroptosis through Hippo\/YAP signaling in prostate cancer progression","volume":"15","author":"Gu","year":"2024","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.gendis.2025.101967_bib21","article-title":"A ferroptosis-inducing biomimetic nanocomposite for the treatment of drug-resistant prostate cancer","volume":"17","author":"Chen","year":"2022","journal-title":"Mater Today Bio"},{"issue":"1","key":"10.1016\/j.gendis.2025.101967_bib22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1021\/acscentsci.9b01063","article-title":"GTP cyclohydrolase 1\/tetrahydrobiopterin counteract ferroptosis through lipid remodeling","volume":"6","author":"Kraft","year":"2020","journal-title":"ACS Cent Sci"},{"issue":"49","key":"10.1016\/j.gendis.2025.101967_bib23","doi-asserted-by":"crossref","first-page":"31189","DOI":"10.1073\/pnas.2017152117","article-title":"Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis","volume":"117","author":"Yi","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.gendis.2025.101967_bib24","article-title":"Taurine inhibits ferroptosis mediated by the crosstalk between tumor cells and tumor-associated macrophages in prostate cancer","volume":"11","author":"Xiao","year":"2024","journal-title":"Adv Sci (Weinh)"},{"issue":"12","key":"10.1016\/j.gendis.2025.101967_bib25","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/s41589-020-0613-y","article-title":"Metabolic determinants of cancer cell sensitivity to canonical ferroptosis inducers","volume":"16","author":"Soula","year":"2020","journal-title":"Nat Chem Biol"},{"issue":"7746","key":"10.1016\/j.gendis.2025.101967_bib26","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41586-019-0945-5","article-title":"Squalene accumulation in cholesterol auxotrophic lymphomas prevents oxidative cell death","volume":"567","author":"Garcia-Bermudez","year":"2019","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.gendis.2025.101967_bib27","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.3390\/biomedicines10112834","article-title":"Emerging role of YAP and the Hippo pathway in prostate cancer","volume":"10","author":"Koinis","year":"2022","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.gendis.2025.101967_bib28","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.gendis.2020.05.004","article-title":"Regulation of ferroptosis in cancer cells by YAP\/TAZ and Hippo pathways: the therapeutic implications","volume":"8","author":"Sun","year":"2021","journal-title":"Genes Dis"},{"issue":"8","key":"10.1016\/j.gendis.2025.101967_bib29","doi-asserted-by":"crossref","first-page":"7482","DOI":"10.3390\/ijms24087482","article-title":"The molecular biology of prostate cancer stem cells: from the past to the future","volume":"24","author":"Zhou","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"19","key":"10.1016\/j.gendis.2025.101967_bib30","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1158\/0008-5472.CAN-23-0285","article-title":"Androgen receptor variants confer castration resistance in prostate cancer by counteracting antiandrogen-induced ferroptosis","volume":"83","author":"Sun","year":"2023","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.gendis.2025.101967_bib31","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3390\/cells13110951","article-title":"Impact of oncogenic changes in p53 and KRAS on macropinocytosis and ferroptosis in colon cancer cells and anticancer efficacy of niclosamide with differential effects on these two processes","volume":"13","author":"Nguyen","year":"2024","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.gendis.2025.101967_bib32","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41420-023-01430-0","article-title":"Ferroptosis landscape in prostate cancer from molecular and metabolic perspective","volume":"9","author":"Liang","year":"2023","journal-title":"Cell Death Discov"},{"issue":"3","key":"10.1016\/j.gendis.2025.101967_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.clnves.2025.100020","article-title":"Activation of the NRF2 signaling pathway mitigates arthrofibrosis by suppressing myofibroblast ferroptosis through oxidative stress regulation","volume":"1","author":"Zhu","year":"2025","journal-title":"Cell Investig"},{"issue":"8","key":"10.1016\/j.gendis.2025.101967_bib34","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41419-022-05108-w","article-title":"SOX15 transcriptionally increases the function of AOC1 to modulate ferroptosis and progression in prostate cancer","volume":"13","author":"Ding","year":"2022","journal-title":"Cell Death Dis"},{"issue":"4","key":"10.1016\/j.gendis.2025.101967_bib35","doi-asserted-by":"crossref","first-page":"378","DOI":"10.21147\/j.issn.1000-9604.2024.04.03","article-title":"SOX11 as a potential prognostic biomarker in hepatocellular carcinoma linked to immune infiltration and ferroptosis","volume":"36","author":"Chen","year":"2024","journal-title":"Chin J Cancer Res"},{"issue":"9","key":"10.1016\/j.gendis.2025.101967_bib36","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.21037\/tau-24-415","article-title":"Ferroptosis-related gene signature predicts prognosis and immune microenvironment in prostate cancer","volume":"13","author":"Wang","year":"2024","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.gendis.2025.101967_bib37","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1016\/j.csbj.2022.06.046","article-title":"Identifies microtubule-binding protein CSPP1 as a novel cancer biomarker associated with ferroptosis and tumor microenvironment","volume":"20","author":"Wang","year":"2022","journal-title":"Comput Struct Biotechnol J"},{"key":"10.1016\/j.gendis.2025.101967_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100985","article-title":"Inhibition of phosphoglycerate dehydrogenase induces ferroptosis and overcomes enzalutamide resistance in castration-resistant prostate cancer cells","volume":"70","author":"Wang","year":"2023","journal-title":"Drug Resist Updat"},{"issue":"2","key":"10.1016\/j.gendis.2025.101967_bib39","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.apsb.2021.07.016","article-title":"Abrogation of HnRNP L enhances anti-PD-1 therapy efficacy via diminishing PD-L1 and promoting CD8+ T cell-mediated ferroptosis in castration-resistant prostate cancer","volume":"12","author":"Zhou","year":"2022","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"10.1016\/j.gendis.2025.101967_bib40","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s12951-024-02496-3","article-title":"Irradiated microparticles suppress prostate cancer by tumor microenvironment reprogramming and ferroptosis","volume":"22","author":"Deng","year":"2024","journal-title":"J Nanobiotechnology"},{"issue":"8011","key":"10.1016\/j.gendis.2025.101967_bib41","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41586-024-07352-w","article-title":"PGE(2) inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function","volume":"629","author":"Morotti","year":"2024","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.gendis.2025.101967_bib42","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41420-023-01304-5","article-title":"Simultaneous blockade of VEGF-B and IL-17A ameliorated diabetic kidney disease by reducing ectopic lipid deposition and alleviating inflammation response","volume":"9","author":"Cao","year":"2023","journal-title":"Cell Death Discov"},{"issue":"1","key":"10.1016\/j.gendis.2025.101967_bib43","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13046-024-03063-2","article-title":"Icaritin-curcumol activates CD8+ T cells through regulation of gut microbiota and the DNMT1\/IGFBP2 axis to suppress the development of prostate cancer","volume":"43","author":"Xu","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.gendis.2025.101967_bib44","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1158\/0008-5472.CAN-20-3477","article-title":"Ferroptosis inducers are a novel therapeutic approach for advanced prostate cancer","volume":"81","author":"Ghoochani","year":"2021","journal-title":"Cancer Res"},{"key":"10.1016\/j.gendis.2025.101967_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114741","article-title":"RSL3 enhances the antitumor effect of cisplatin on prostate cancer cells via causing glycolysis dysfunction","volume":"192","author":"Li","year":"2021","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101967_bib46","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41420-023-01383-4","article-title":"Iron supplementation enhances RSL3-induced ferroptosis to treat na\u00efve and prevent castration-resistant prostate cancer","volume":"9","author":"Maccarinelli","year":"2023","journal-title":"Cell Death Discov"},{"issue":"1","key":"10.1016\/j.gendis.2025.101967_bib47","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13046-023-02920-w","article-title":"TrkA promotes MDM2-mediated AGPS ubiquitination and degradation to trigger prostate cancer progression","volume":"43","author":"Zhang","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.gendis.2025.101967_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107162","article-title":"The interplay between autophagy and ferroptosis presents a novel conceptual therapeutic framework for neuroendocrine prostate cancer","volume":"203","author":"Wang","year":"2024","journal-title":"Pharmacol Res"},{"issue":"4","key":"10.1016\/j.gendis.2025.101967_bib49","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3892\/or.2021.7976","article-title":"Ferroptosis inducer Erastin downregulates androgen receptor and its splice variants in castration-resistant prostate cancer","volume":"45","author":"Yang","year":"2021","journal-title":"Oncol Rep"},{"key":"10.1016\/j.gendis.2025.101967_bib50","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.freeradbiomed.2025.06.030","article-title":"Herbacetin alleviates ferroptosis via Hif-1\u03b1\/SLC7A11\/GPX4 axis in traumatic brain injury","volume":"238","author":"Qian","year":"2025","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"10.1016\/j.gendis.2025.101967_bib51","doi-asserted-by":"crossref","first-page":"176","DOI":"10.21147\/j.issn.1000-9604.2023.02.07","article-title":"Aqueous-soluble components of sporoderm-removed Ganoderma lucidum spore powder promote ferroptosis in oral squamous cell carcinoma","volume":"35","author":"Wu","year":"2023","journal-title":"Chin J Cancer Res"},{"issue":"9","key":"10.1016\/j.gendis.2025.101967_bib52","first-page":"1528","article-title":"PX-12 inhibits the growth of hepatocelluar carcinoma by inducing S-phase arrest, ROS-dependent apoptosis and enhances 5-FU cytotoxicity","volume":"7","author":"Li","year":"2015","journal-title":"Am J Transl Res"},{"issue":"1","key":"10.1016\/j.gendis.2025.101967_bib53","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13020-024-00881-6","article-title":"Sanguinarine chloride induces ferroptosis by regulating ROS\/BACH1\/HMOX1 signaling pathway in prostate cancer","volume":"19","author":"Liu","year":"2024","journal-title":"Chin Med"},{"issue":"7","key":"10.1016\/j.gendis.2025.101967_bib54","doi-asserted-by":"crossref","first-page":"874","DOI":"10.3390\/ph17070874","article-title":"Biflavonoids: preliminary reports on their role in prostate and breast cancer therapy","volume":"17","author":"de Lima","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"4","key":"10.1016\/j.gendis.2025.101967_bib55","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.molcel.2016.09.037","article-title":"An autophagic flux probe that releases an internal control","volume":"64","author":"Kaizuka","year":"2016","journal-title":"Mol Cell"},{"issue":"7679","key":"10.1016\/j.gendis.2025.101967_bib56","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature24297","article-title":"Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition","volume":"551","author":"Hangauer","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.gendis.2025.101967_bib57","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.canlet.2016.07.035","article-title":"Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer","volume":"381","author":"Roh","year":"2016","journal-title":"Cancer Lett"},{"issue":"1","key":"10.1016\/j.gendis.2025.101967_bib58","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.28251","article-title":"Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells","volume":"63","author":"Sun","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.gendis.2025.101967_bib59","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.3389\/fphar.2018.01371","article-title":"RSL3 drives ferroptosis through GPX4 inactivation and ROS production in colorectal cancer","volume":"9","author":"Sui","year":"2018","journal-title":"Front Pharmacol"},{"issue":"7","key":"10.1016\/j.gendis.2025.101967_bib60","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nchembio.2079","article-title":"Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis","volume":"12","author":"Shimada","year":"2016","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.gendis.2025.101967_bib61","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/j.biopha.2018.11.030","article-title":"Artesunate alleviates liver fibrosis by regulating ferroptosis signaling pathway","volume":"109","author":"Kong","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.gendis.2025.101967_bib62","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.freeradbiomed.2018.12.011","article-title":"DHA inhibits proliferation and induces ferroptosis of leukemia cells through autophagy dependent degradation of ferritin","volume":"131","author":"Du","year":"2019","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"10.1016\/j.gendis.2025.101967_bib63","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/02601060211018360","article-title":"Can diallyl trisulfide, a dietary garlic-derived compound, activate ferroptosis to overcome therapy resistance in prostate cancer?","volume":"28","author":"Samy","year":"2022","journal-title":"Nutr Health"},{"issue":"2","key":"10.1016\/j.gendis.2025.101967_bib64","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4143\/crt.2016.572","article-title":"Ferroptosis: a novel anti-tumor action for cisplatin","volume":"50","author":"Guo","year":"2018","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.gendis.2025.101967_bib65","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3469840","article-title":"Transcriptome investigation and in vitro verification of curcumin-induced HO-1 as a feature of ferroptosis in breast cancer cells","volume":"2020","author":"Li","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.gendis.2025.101967_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105305","article-title":"Flubendazole, FDA-approved anthelmintic, elicits valid antitumor effects by targeting P53 and promoting ferroptosis in castration-resistant prostate cancer","volume":"164","author":"Zhou","year":"2021","journal-title":"Pharmacol Res"},{"issue":"1\u20132","key":"10.1016\/j.gendis.2025.101967_bib67","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.gendis.2025.101967_bib68","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/s41419-018-1192-7","article-title":"Calcimimetic restores diabetic peripheral neuropathy by ameliorating apoptosis and improving autophagy","volume":"9","author":"Chung","year":"2018","journal-title":"Cell Death Dis"},{"issue":"8","key":"10.1016\/j.gendis.2025.101967_bib69","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2017.65","article-title":"Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis","volume":"6","author":"Fan","year":"2017","journal-title":"Oncogenesis"},{"issue":"7","key":"10.1016\/j.gendis.2025.101967_bib70","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.208","article-title":"Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells","volume":"7","author":"Ma","year":"2016","journal-title":"Cell Death Dis"},{"issue":"12","key":"10.1016\/j.gendis.2025.101967_bib71","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.7150\/ijbs.101039","article-title":"Darolutamide-mediated phospholipid remodeling induces ferroptosis through the SREBP1-FASN axis in prostate cancer","volume":"20","author":"Li","year":"2024","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.gendis.2025.101967_bib72","article-title":"Ferroptosis induction improves the sensitivity of docetaxel in prostate cancer","volume":"2022","author":"Chen","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.gendis.2025.101967_bib73","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.3389\/fonc.2019.01398","article-title":"Erastin reverses ABCB1-mediated docetaxel resistance in ovarian cancer","volume":"9","author":"Zhou","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.gendis.2025.101967_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176341","article-title":"Metformin improves nonalcoholic fatty liver disease in db\/db mice by inhibiting ferroptosis","volume":"966","author":"Zhang","year":"2024","journal-title":"Eur J Pharmacol"},{"issue":"13","key":"10.1016\/j.gendis.2025.101967_bib75","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1016\/j.cell.2023.05.003","article-title":"Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones","volume":"186","author":"Liang","year":"2023","journal-title":"Cell"},{"issue":"33","key":"10.1016\/j.gendis.2025.101967_bib76","article-title":"Genetically engineered membrane-coated nanoparticles for enhanced prostate-specific membrane antigen targeting and ferroptosis treatment of castration-resistant prostate cancer","volume":"11","author":"Li","year":"2024","journal-title":"Adv Sci (Weinh)"},{"issue":"8","key":"10.1016\/j.gendis.2025.101967_bib77","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/cac2.12321","article-title":"The establishment of polypeptide PSMA-targeted chimeric antigen receptor-engineered natural killer cells for castration-resistant prostate cancer and the induction of ferroptosis-related cell death","volume":"42","author":"Wu","year":"2022","journal-title":"Cancer Commun (Lond)"},{"issue":"1","key":"10.1016\/j.gendis.2025.101967_bib78","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s10238-025-01722-y","article-title":"Mechanism and role of ferroptosis in the development of gastric cancer","volume":"25","author":"Wei","year":"2025","journal-title":"Clin Exp Med"},{"issue":"12","key":"10.1016\/j.gendis.2025.101967_bib79","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.7150\/jca.84363","article-title":"QiLing Decoction promotes ferroptosis of castration-resistant prostate cancer cells by inhibiting FSP1 in vitro and in vivo","volume":"14","author":"Cao","year":"2023","journal-title":"J Cancer"},{"issue":"1","key":"10.1016\/j.gendis.2025.101967_bib80","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00726-011-0864-8","article-title":"The transsulfuration pathway: a source of cysteine for glutathione in astrocytes","volume":"42","author":"McBean","year":"2012","journal-title":"Amino Acids"},{"issue":"9","key":"10.1016\/j.gendis.2025.101967_bib81","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.tcb.2022.02.009","article-title":"Transsulfuration, minor player or crucial for cysteine homeostasis in cancer","volume":"32","author":"Zhang","year":"2022","journal-title":"Trends Cell Biol"},{"issue":"9","key":"10.1016\/j.gendis.2025.101967_bib82","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41419-024-07007-8","article-title":"Phosphatase LHPP confers prostate cancer ferroptosis activation by modulating the AKT-SKP2-ACSL4 pathway","volume":"15","author":"Xie","year":"2024","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.gendis.2025.101967_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107915","article-title":"Precision targeting of androgen receptor-ferroptosis crosstalk in prostate cancer: from mechanisms to therapeutic strategies","volume":"219","author":"Lv","year":"2025","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.gendis.2025.101967_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103392","article-title":"HJURP inhibits sensitivity to ferroptosis inducers in prostate cancer cells by enhancing the peroxidase activity of PRDX1","volume":"77","author":"Lai","year":"2024","journal-title":"Redox Biol"},{"key":"10.1016\/j.gendis.2025.101967_bib85","article-title":"Advances in ferroptosis for castration-resistant prostate cancer treatment: novel drug targets and combination therapy strategies","author":"Chen","year":"202629136","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"5","key":"10.1016\/j.gendis.2025.101967_bib86","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1678","article-title":"Cyclin-dependent kinase 12 deficiency reprogrammes cellular metabolism to alleviate ferroptosis potential and promote the progression of castration-resistant prostate cancer","volume":"14","author":"Zhang","year":"2024","journal-title":"Clin Transl Med"}],"container-title":["Genes & Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304225004568?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304225004568?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T15:45:37Z","timestamp":1782229537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352304225004568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":86,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2352304225004568"],"URL":"https:\/\/doi.org\/10.1016\/j.gendis.2025.101967","relation":{},"ISSN":["2352-3042"],"issn-type":[{"value":"2352-3042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ferroptosis and prostate cancer: A translational path from molecular mechanisms to precision therapy","name":"articletitle","label":"Article Title"},{"value":"Genes & Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gendis.2025.101967","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101967"}}